- Home
- GSUN vs CVKD Comparison
GSUN vs CVKD Comparison
Compare GSUN & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSUN
- CVKD
- Stock Information
- Founded
- GSUN 1997
- CVKD 2022
- Country
- GSUN China
- CVKD United States
- Employees
- GSUN N/A
- CVKD N/A
- Industry
- GSUN Other Consumer Services
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- GSUN Real Estate
- CVKD Health Care
- Exchange
- GSUN Nasdaq
- CVKD Nasdaq
- Market Cap
- GSUN 24.0M
- CVKD 27.0M
- IPO Year
- GSUN 2022
- CVKD 2023
- Fundamental
- Price
- GSUN $2.67
- CVKD $12.84
- Analyst Decision
- GSUN
- CVKD Strong Buy
- Analyst Count
- GSUN 0
- CVKD 1
- Target Price
- GSUN N/A
- CVKD $32.00
- AVG Volume (30 Days)
- GSUN 82.2K
- CVKD 28.0K
- Earning Date
- GSUN 10-31-2025
- CVKD 11-06-2025
- Dividend Yield
- GSUN N/A
- CVKD N/A
- EPS Growth
- GSUN N/A
- CVKD N/A
- EPS
- GSUN N/A
- CVKD N/A
- Revenue
- GSUN $25,314,724.00
- CVKD N/A
- Revenue This Year
- GSUN N/A
- CVKD N/A
- Revenue Next Year
- GSUN N/A
- CVKD N/A
- P/E Ratio
- GSUN N/A
- CVKD N/A
- Revenue Growth
- GSUN 526.22
- CVKD N/A
- 52 Week Low
- GSUN $1.82
- CVKD $8.74
- 52 Week High
- GSUN $5.25
- CVKD $22.90
- Technical
- Relative Strength Index (RSI)
- GSUN 53.00
- CVKD 41.79
- Support Level
- GSUN $2.38
- CVKD $13.51
- Resistance Level
- GSUN $2.70
- CVKD $14.35
- Average True Range (ATR)
- GSUN 0.21
- CVKD 0.52
- MACD
- GSUN 0.02
- CVKD -0.13
- Stochastic Oscillator
- GSUN 80.48
- CVKD 4.79
About GSUN Golden Sun Education Group Limited
Golden Sun Health Technology Group Ltd is a holding company. Along with its subsidiaries, it is engaged in the provision of education services and e-commerce business in the People's Republic of China. It offers tutorial centers for children and adults, one educational company that partners with high schools to offer language classes to their students, and one logistics company that provides logistics and consulting services. It has also established its wellness brands and an e-commerce platform to promote and sell wellness products. The company operates in the following segments; Education, which generates maximum revenue, and E-commerce.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.